Log in to save to my catalogue

Combination inhibition of PI3K and mTORC1 yields durable remissions in mice bearing orthotopic patie...

Combination inhibition of PI3K and mTORC1 yields durable remissions in mice bearing orthotopic patie...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1808733447

Combination inhibition of PI3K and mTORC1 yields durable remissions in mice bearing orthotopic patient-derived xenografts of HER2-positive breast cancer brain metastases

About this item

Full title

Combination inhibition of PI3K and mTORC1 yields durable remissions in mice bearing orthotopic patient-derived xenografts of HER2-positive breast cancer brain metastases

Publisher

New York: Nature Publishing Group US

Journal title

Nature medicine, 2016-07, Vol.22 (7), p.723-726

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

Subjects

Subjects and topics

More information

Scope and Contents

Contents

In mouse models of patient-derived breast cancer brain metastases, combined inhibition of PI3K and mTOR resulted in regression, and therapeutic response was correlated with a reduction in 4EBP1 phosphorylation.
Brain metastases represent the greatest clinical challenge in treating HER2-positive breast cancer. We report the development of orthoto...

Alternative Titles

Full title

Combination inhibition of PI3K and mTORC1 yields durable remissions in mice bearing orthotopic patient-derived xenografts of HER2-positive breast cancer brain metastases

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1808733447

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1808733447

Other Identifiers

ISSN

1078-8956

E-ISSN

1546-170X

DOI

10.1038/nm.4120

How to access this item